Blocking CXCR3B Expression Increases Tumor Aggressiveness in Hepatocellular Carcinoma
Anticancer Research · 2024
DOI: 10.21873/anticanres.17357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Hwan Hee Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Duksung Women's University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Receptors, CXCR3, Cell Movement. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Duksung Women's University, Seoul, Republic of Korea.
- Duksung Innovative Drug Center, Duksung Women's University, Seoul, Republic of Korea.
- Vessel-Organ Interaction Research Center, VOICE (MRC), College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea hkang72@knu.ac.kr.
- College of Pharmacy, Duksung Women's University, Seoul, Republic of Korea; hyosun1102@duksung.ac.kr.
Zitieren
APA
Lee, H. H., Oh, S., Kang, H., & Cho, H. (2024). Blocking CXCR3B Expression Increases Tumor Aggressiveness in Hepatocellular Carcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.17357
Vancouver
Lee HH, Oh S, Kang H, Cho H. Blocking CXCR3B Expression Increases Tumor Aggressiveness in Hepatocellular Carcinoma. Anticancer Research. 2024. doi:10.21873/anticanres.17357
BibTeX
@article{Lee2024,
author = {Lee, Hwan Hee and Oh, Seoyeon and Kang, Hyojeung and Cho, Hyosun},
title = {Blocking CXCR3B Expression Increases Tumor Aggressiveness in Hepatocellular Carcinoma},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17357}
}
EUVIMED